Creative Medical Technology Holdings, Inc. (CELZ) vs Jaguar Health, Inc. (JAGX)
A side-by-side comparison of Creative Medical Technology Holdings, Inc. and Jaguar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELZ
Creative Medical Technology Holdings, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 11:32 AM EDT
JAGX
Jaguar Health, Inc.
$5.80HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — CELZ vs JAGX
growth of $100 · dividends reinvested · last 10yCELZ -100.0% (-56.6%/yr)JAGX -100.0% (-82.8%/yr)CELZ compounded faster over this window
Log scale — wide-divergence pair
CELZ JAGX
CELZ vs JAGX: by the numbers
- •JAGX is the larger company ($3M vs $2M market cap).
- •Both run net losses; JAGX's is the smaller (-131.76% vs -201355.37% net margin).
- •JAGX grew revenue faster over the past five years (31.88% vs -50.85% CAGR).
Metrics side by side
Valuation
| Metric | CELZ | JAGX |
|---|---|---|
| P/S ratio | 777.64 | 0.09 |
| P/B ratio | 0.27 | 0.38 |
Profitability
| Metric | CELZ | JAGX |
|---|---|---|
| Gross margin | 63.43% | 67.21% |
| Operating margin | -102380.23% | -391.87% |
| Net margin | -201355.37% | -131.76% |
| ROE | -69.79% | -554.01% |
| ROIC | -71.90% | -110.81% |
Growth (annualized)
| Metric | CELZ | JAGX |
|---|---|---|
| Revenue CAGR (5Y) | -50.85% | 31.88% |
| Total return CAGR (5Y) | -57.96% | N/A |
Frequently asked
- Which has grown faster, CELZ or JAGX?
- Over the past five years, JAGX grew revenue faster — CELZ at a -50.85% CAGR versus JAGX at 31.88%.
Go deeper
Dig into the metrics
Creative Medical Technology ROEJaguar Health ROECreative Medical Technology operating marginJaguar Health operating marginCreative Medical Technology revenue growthJaguar Health revenue growthCreative Medical Technology free cash flowJaguar Health free cash flow
Creative Medical Technology & Jaguar Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.